Otterbein University

Digital Commons @ Otterbein
Nursing Student Class Projects (Formerly MSN)

Student Research & Creative Work

6-2016

Portal Hypertension
Kristi Loomis
Otterbein University, kristi.loomis@otterbein.edu

Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn
Part of the Nursing Commons

Recommended Citation
Loomis, Kristi, "Portal Hypertension" (2016). Nursing Student Class Projects (Formerly MSN). 140.
https://digitalcommons.otterbein.edu/stu_msn/140

This Project is brought to you for free and open access by the Student Research & Creative Work at Digital
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an
authorized administrator of Digital Commons @ Otterbein. For more information, please contact
digitalcommons07@otterbein.edu.

Portal Hypertension
Kristi Loomis RN, BSN
Otterbein University, Westerville, Ohio
Introduction
Chronic liver disease plagues the body
with many significant complications. One
of the more commonly identified
complications is portal hypertension
(PHT). Without intervention the elevated
pressures in PHT will lead to extensive
complications, and eventually death. I
chose to research this pathological
process due to the frequent presentation
of PHT related complications in my line of
healthcare.

Pathophysiological
Processes

Portal hypertension causes many
clinically identifiable complications:

Long-term
PHT Signs
•Esophageal & Gastric Varices (See image)
• Splenomegaly
• Ascites
• Jaundice
• Sepsis syndrome
• Caput Medusae
• Portosystemic encephalopathy
Esophageal Varices

Portal hypertension can be simply
defined as increased hepatic venous
pressure. Bloom, Kemp, and Lubel
(2015) describe PHT “as hepatic
venous pressure gradient (HVPG)
greater than 5 mmHg, with
complications arising once this
exceeds 10 mmHg” (p. 16). The
increased hepatic venous pressure is
generally caused by portal blood flow
resistance, which leads to vascular
resistance constraining portal flow,
which then creates higher portal
pressures, also known as PHT (Iwakiri,
2014). Many different liver disorders
contribute to the development of
portal hypertension.

Pre-hepatic
Etiology:
•Thrombosis
• Narrowing of the hepatic portal vein

Intra-hepatic
Etiology:
•Vascular remodeling
• Intrahepatic shunts
• Thrombosis
• Inflammation
• Fibrosis/cirrhosis
• Viral hepatitis
• Schistosomiasis

Post-hepatic
Etiology:
• Hepatic vein thrombosis
• Right sided cardiac disorders

Significance of
Pathophysiology

Underlying Pathophysiology
The underlying pathophysiology of the increased hepatic
resistance is caused by “the distortion of liver
architecture associated with fibrogenesis and
angiogenesis, and by increased vascular hepatic tone
due to intrahepatic vasoconstriction secondary to an
imbalance between decreased endogenous dilators and
increased vasoconstrictor stimuli” (Fernandez, 2015,
p.1407). “Portal Hypertension is aggravated by an
augmented blood flow in the splanchnic organs draining
into the portal vein due to enhanced vasodilation and
angiogenesis, and subsequent elevation in portal venous
inflow which significantly affects the progression of PHT”
(Fernandez, 2015, p.1407). The increased splanchnic flow
contributes to formation of ascites, bacterial peritonitis,
and portosystemic collateral vessels (Fernandez, 2015).
Molecular components such as decreased nitric oxide
(NO), increased endothelin, eicosanoids, increased nogoB, and decrease in microRNAs, also lead to increased
intrahepatic vascular resistance (IHVR), thus potentiating
PHT.

Long term portal hypertension can be
difficult to treat and leads to severe
complications with life threatening
consequences. Formation of
portosystemic collateral vessels due to
PHT has been identified as the main
causative factor for gastroesophageal
variceal hemorrhage, portosystemic
encephalopathy, and sepsis (Fernandez,
2015). According to Carale, Azer, &
Mekaroonkamol (2015), “the estimated
mortality for the first episode of variceal
hemorrhage is 30-50%” (p. 9). The high
incidence of mortality from variceal
hemorrhage lends evidence as to why
portal hypertension is a significant
factor for those with liver disease. Early
intervention and disease surveillance is
of primary concern when dealing with
PHT.

Breakdown of PHT:
•
•
•
•
•
•
•

Increased hydrostatic pressure in portal vein
causes backpressure and splanchnic vasodilation
Blood retained in dilated vessels
Retained blood decreases renal flow and excites
Renin-Angiotensin-Aldosterone (RAA) cascade
Elevated Aldosterone levels try to compensate for
decreased blood volume increase total body water
and sodium levels.
Decreased serum albumin d/t diluted body water &
decreased production from liver
Decreased intravascular oncotic pressure d/t
decreased serum albumin
Filtration into ISF d/t decreased intravascular
oncotic pressure

Implications for
Nursing Care
Fernandez, M. (2015). Molecular pathophysiology of portal hypertension [Untitled
illustration]. Hepatology, 61(4), 1406-1415. doi:10.1002/hep.27343

Esophageal Varices [Online image]. Retrieved June 28, 2016
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Hepatorenal PHT
Symptoms:
Portal hypertension is generally
asymptomatic, but there are symptoms
related to the complicated side effects of
having elevated hepatic pressures:
•Variceal hemorrhage causing
hematemesis or black tarry stools
• Mental status changes
•Abdominal distention
• Asterixis
• Tiredness
• Edema
• Decreased Urine Output

Implications for nursing care are
primarily related to assessing,
monitoring, preventing, and treating
complications related to PHT. The
advanced nurse practitioner will monitor
labs, prescribe prophylactic medications
such as vasoactive agents to control
blood pressures and decrease the risk of
esophageal varices, as well as diuretic
therapy to reduce fluid volume excess if
indicated. Patient education on signs
and symptoms of complications is a very
important nursing implication.
Nurse practitioners will order studies
such as liver and abdominal ultrasounds,
and barium swallow testing to assist in
the identification of portal hypertension.
The nurse practitioner will also as
collaborate with other specialists to
manage the disease process.
Gastrointestinal and radiology specialist
perform lifesaving procedures such as
endoscopic variceal band ligation (EVBL)
to stop bleeding varices, or transjugular
intrahepatic portosystemic shunt (TIPS)
procedure which helps to reduce portal
pressure.
Patient Education Tips:
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• Monitor for S/S of bleeding
• Monitor platelet counts & INR
•Monitor for S/S of ascites (i.e.
Increased abdominal girth, bulging
flanks, abdominal fluid wave)

Conclusion

References Continued

Portal hypertension is a complex,
multifactorial complication of liver
disease. Collaborative care is necessary
to successfully manage and delay
progression of the disease process.
Quick identification of clinical signs of
portal hypertension is essential to
reducing mortality rates and improving
quality of living for affected patients.
Addressing and treating the underlying
cause of PHT is paramount for longterm survival. Failure to effectively treat
PHT will have disastrous consequences,
ultimately leading to death.
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